Veru Inc (VERU)
Veru Market Cap: 193.23M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 193.23M |
May 16, 2024 | 200.55M |
May 15, 2024 | 215.18M |
May 14, 2024 | 215.18M |
May 13, 2024 | 194.69M |
May 10, 2024 | 194.69M |
May 09, 2024 | 200.55M |
May 08, 2024 | 209.33M |
May 07, 2024 | 238.61M |
May 06, 2024 | 240.07M |
May 03, 2024 | 238.60M |
May 02, 2024 | 240.07M |
May 01, 2024 | 218.11M |
April 30, 2024 | 197.61M |
April 29, 2024 | 182.98M |
April 26, 2024 | 185.90M |
April 25, 2024 | 177.12M |
April 24, 2024 | 193.22M |
April 23, 2024 | 186.64M |
April 22, 2024 | 185.90M |
April 19, 2024 | 191.76M |
April 18, 2024 | 207.86M |
April 17, 2024 | 169.80M |
April 16, 2024 | 183.71M |
April 15, 2024 | 223.96M |
Date | Value |
---|---|
April 12, 2024 | 222.50M |
April 11, 2024 | 262.02M |
April 10, 2024 | 181.51M |
April 09, 2024 | 171.27M |
April 08, 2024 | 150.77M |
April 05, 2024 | 135.42M |
April 04, 2024 | 121.50M |
April 03, 2024 | 121.35M |
April 02, 2024 | 113.33M |
April 01, 2024 | 111.25M |
March 28, 2024 | 102.48M |
March 27, 2024 | 94.65M |
March 26, 2024 | 89.28M |
March 25, 2024 | 89.18M |
March 22, 2024 | 81.97M |
March 21, 2024 | 84.01M |
March 20, 2024 | 86.36M |
March 19, 2024 | 88.02M |
March 18, 2024 | 83.09M |
March 15, 2024 | 84.90M |
March 14, 2024 | 87.84M |
March 13, 2024 | 93.83M |
March 12, 2024 | 92.37M |
March 11, 2024 | 96.32M |
March 08, 2024 | 94.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
EyePoint Pharmaceuticals Inc | 616.68M |
INVO Bioscience Inc | 2.702M |
Bio-Path Holdings Inc | 1.453M |
Aileron Therapeutics Inc | 79.71M |
ProKidney Corp | 259.21M |
Market Cap Related Metrics
PS Ratio | 10.42 |
Price to Book Value | 4.274 |
Price | 1.32 |
Earnings Yield | -25.76% |